Donald Healey
Vermögen: 29 825 $ am 30.06.2026
Vermögen: 29 825 $ am 30.06.2026
Donald Healey currently works at Adicet Bio, Inc., as Chief Technology Officer from 2020.
Dr. Healey also formerly worked at Argos Therapeutics, Inc., as Director-Immunology, KBI Biopharma, Inc., as Senior Vice President-Operations from 2017 to 2020, Opexa Therapeutics, Inc., as Chief Scientific Officer from 2013 to 2017, and British Society for Immunology, as Council Member in 1998.
Dr. Healey received his doctorate degree from the University of London and undergraduate degree from the University of Bristol.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADICET BIO INC 0.04% | 25.03.2026 | 3’452 ( 0.04% ) | 29 825 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ADICET BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 26.10.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Geschäftsführer | 01.10.2020 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2017 |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services Provides membership organizations services | Corporate Officer/Principal | 01.01.1998 |
| ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Commercial Services |
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services Provides membership organizations services | Commercial Services |
Adicet Bio, Inc.
Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen